[Side effects of cardiac glycosides, calcium antagonists and beta blockers in the secondary data of the legal health insurance].
Krappweis
J
J
von Ferber
L
L
Köster
I
I
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D002121:Calcium Channel Blockers / Q000009:adverse effects*; D002301:Cardiac Glycosides / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D005860:Germany, West; D006801:Humans; D011358:Product Surveillance, Postmarketing; D012307:Risk Factors
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D002301:Cardiac Glycosides
Untersuchung unerwünschter Arzneiwirkungen (UAW) bei herzwirksamen Glykosiden, Calciumantagonisten und Beta-Blockern an Sekundärdaten der Gesetzlichen Krankenversicherung.